NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PACS Group, Inc. ("PACS" or the "Company") (NYSE: PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") in connection with the Company's April 11, 2024 initial public offering ("IPO"); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the "Class Period"); and/or (iii) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's September 2024 secondary public offering ("SPO"), of the important January 13, 2025 lead plaintiff deadline.

LOS ANGELES, Dec. 20, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against PACS Group, Inc. ("PACS Group" or the "Company") (NYSE: PACS).

Class Period: April 11, 2024 – November 5, 2024Lead Plaintiff Deadline: January 13, 2025

If you are a shareholder who suffered a loss, click here to participate.

NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in PACS Group, Inc. ("PACS Group, Inc." or the "Company") (NYSE: PACS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PACS Group, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired PACS Group: (a) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's April 11, 2024 initial public offering; and/or (b) securities between April 11, 2024 and November 5, 2024 inclusive. Follow the link below to get more information and be contacted by a member of our team:

BENSALEM, Pa., Dec. 19, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against PACS Group, Inc. ("PACS Group" or the "Company") (NYSE: PACS).

Class Period: April 11, 2024 – November 5, 2024

Lead Plaintiff Deadline: January 13, 2025

Investors suffering losses on their PACS Group investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 215-638-4847 or by email to howardsmith@howardsmithlaw.com.

BENSALEM, Pa., Dec. 19, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against PACS Group, Inc. ("PACS Group" or the "Company") (NYSE: PACS).

Class Period: April 11, 2024 – November 5, 2024

Lead Plaintiff Deadline: January 13, 2025

Investors suffering losses on their PACS Group investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 215-638-4847 or by email to howardsmith@howardsmithlaw.com.

SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of PACS Group, Inc. (NYSE: PACS): (i) securities between April 11, 2024 and November 5, 2024, inclusive (the "Class Period"); and/or (ii) common stock pursuant and/or traceable to PACS Group's registration statement issued in connection with PACS Group's April 11, 2024 initial public offering ("IPO"), have until Monday, January 13, 2025 to seek appointment as lead plaintiff of the PACS Group class action lawsuit.  Captioned Manchin v. PACS Group, Inc., No. 24-cv-08636 (S.D.N.Y.), the PACS Group class action lawsuit charges PACS Group and certain of PACS Group's top executives, directors, and certain underwriters of the IPO with violations of the Securities Act of 1933 and/or the Securities Exchange Act of 1934.

NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in PACS Group, Inc. ("PACS Group, Inc." or the "Company") (NYSE: PACS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PACS Group, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on  behalf of persons and entities that purchased or otherwise acquired PACS Group: (a) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's April 11, 2024 initial public offering; and/or (b) securities between April 11, 2024 and November 5, 2024 inclusive. Follow the link below to get more information and be contacted by a member of our team:

NEW YORK, Dec. 16, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS).

Shareholders who purchased shares of PACS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

NEW YORK, Dec. 15, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") in connection with the Company's April 11, 2024 initial public offering ("IPO"); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the "Class Period"); and/or (iii) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's September 2024 secondary public offering ("SPO"), of the important January 13, 2025 lead plaintiff deadline.